These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 29698554)

  • 1. Long-term outcome of peanut oral immunotherapy-Real-life experience.
    Nachshon L; Goldberg MR; Katz Y; Levy MB; Elizur A
    Pediatr Allergy Immunol; 2018 Aug; 29(5):519-526. PubMed ID: 29698554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergen-specific oral immunotherapy for peanut allergy.
    Nurmatov U; Venderbosch I; Devereux G; Simons FE; Sheikh A
    Cochrane Database Syst Rev; 2012 Sep; (9):CD009014. PubMed ID: 22972130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose oral immunotherapy for children with anaphylactic peanut allergy in Japan.
    Nagakura KI; Yanagida N; Sato S; Nishino M; Asaumi T; Ogura K; Ebisawa M
    Pediatr Allergy Immunol; 2018 Aug; 29(5):512-518. PubMed ID: 29603410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of desensitizing children highly allergic to peanut by high-dose oral immunotherapy.
    Reier-Nilsen T; Michelsen MM; Lødrup Carlsen KC; Carlsen KH; Mowinckel P; Nygaard UC; Namork E; Borres MP; Håland G
    Allergy; 2019 Feb; 74(2):337-348. PubMed ID: 30225844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial.
    Loke P; Orsini F; Lozinsky AC; Gold M; O'Sullivan MD; Quinn P; Lloyd M; Ashley SE; Pitkin S; Axelrad C; Metcalfe JR; Su EL; Tey D; Robinson MN; Allen KJ; Prescott SL; Galvin AD; Tang MLK;
    Lancet Child Adolesc Health; 2022 Mar; 6(3):171-184. PubMed ID: 35123664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peanut oral immunotherapy using an extensively heated and baked novel composition of peanuts.
    Kidon MI; Shavit R; Levy Y; Haj Yahia S; Machnes-Maayan D; Frizinsky S; Maoz-Segal R; Offenganden I; Kenett RS; Nancy AL; Hovav R
    Pediatr Allergy Immunol; 2024 May; 35(5):e14146. PubMed ID: 38783409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Degree of Desensitization After 1 Year of Early-Life Peanut Oral Immunotherapy: Small Children Oral Immunotherapy (SmaChO) Randomized Controlled Trial.
    Uhl C; Klevebro S; Sverremark-Ekström E; Tedner SG; Brandström J; Papageorgiou C; Melén E; Konradsen JR; Nilsson C; Asarnoj A
    J Allergy Clin Immunol Pract; 2024 May; 12(5):1297-1305. PubMed ID: 38428524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peanut oral immunotherapy in a pediatric allergy clinic: Patient factors associated with clinical outcomes.
    Guarnieri KM; Slack IF; Gadoury-Lévesque V; Eapen AA; Andorf S; Lierl MB
    Ann Allergy Asthma Immunol; 2021 Aug; 127(2):214-222.e4. PubMed ID: 33839246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parent and child perception of quality of life in a randomized controlled peanut oral immunotherapy trial.
    Reier-Nilsen T; Carlsen KCL; Michelsen MM; Drottning S; Carlsen KH; Zhang C; Borres MP; Håland G
    Pediatr Allergy Immunol; 2019 Sep; 30(6):638-645. PubMed ID: 31013372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients.
    Schneider LC; Rachid R; LeBovidge J; Blood E; Mittal M; Umetsu DT
    J Allergy Clin Immunol; 2013 Dec; 132(6):1368-74. PubMed ID: 24176117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral peanut immunotherapy in children with peanut anaphylaxis.
    Blumchen K; Ulbricht H; Staden U; Dobberstein K; Beschorner J; de Oliveira LC; Shreffler WG; Sampson HA; Niggemann B; Wahn U; Beyer K
    J Allergy Clin Immunol; 2010 Jul; 126(1):83-91.e1. PubMed ID: 20542324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peanut Oral Immunotherapy With or Without H
    Chu DK; Freitag T; Marrin A; Walker TD; Avilla E; Freitag A; Spill P; Foster GA; Thabane L; Jordana M; Waserman S
    J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2386-2394. PubMed ID: 35643280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions.
    Wasserman RL; Factor JM; Baker JW; Mansfield LE; Katz Y; Hague AR; Paul MM; Sugerman RW; Lee JO; Lester MR; Mendelson LM; Nacshon L; Levy MB; Goldberg MR; Elizur A
    J Allergy Clin Immunol Pract; 2014; 2(1):91-6. PubMed ID: 24565775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First Real-World Safety Analysis of Preschool Peanut Oral Immunotherapy.
    Soller L; Abrams EM; Carr S; Kapur S; Rex GA; Leo S; Lidman PG; Yeung J; Vander Leek TK; McHenry M; Wong T; Cook VE; Hildebrand KJ; Gerstner TV; Mak R; Lee NJ; Cameron SB; Chan ES
    J Allergy Clin Immunol Pract; 2019; 7(8):2759-2767.e5. PubMed ID: 31002957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and immune regulation with peanut oral immunotherapy.
    Jones SM; Pons L; Roberts JL; Scurlock AM; Perry TT; Kulis M; Shreffler WG; Steele P; Henry KA; Adair M; Francis JM; Durham S; Vickery BP; Zhong X; Burks AW
    J Allergy Clin Immunol; 2009 Aug; 124(2):292-300, 300.e1-97. PubMed ID: 19577283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low dose immunotherapy in very young children to treat peanut allergy.
    Vickery BP
    Expert Rev Clin Immunol; 2016 Dec; 12(12):1251-1253. PubMed ID: 27599211
    [No Abstract]   [Full Text] [Related]  

  • 17. Peanut Oral Immunotherapy: a Current Perspective.
    Patrawala M; Shih J; Lee G; Vickery B
    Curr Allergy Asthma Rep; 2020 Apr; 20(5):14. PubMed ID: 32314071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Immunotherapy in Japanese Children with Anaphylactic Peanut Allergy.
    Nagakura KI; Sato S; Yanagida N; Nishino M; Asaumi T; Ogura K; Ebisawa M
    Int Arch Allergy Immunol; 2018; 175(3):181-188. PubMed ID: 29339650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current opinion and review on peanut oral immunotherapy.
    Deol S; Bird JA
    Hum Vaccin Immunother; 2014; 10(10):3017-21. PubMed ID: 25483680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of a peanut oral immunotherapy protocol in children with peanut allergy.
    Hofmann AM; Scurlock AM; Jones SM; Palmer KP; Lokhnygina Y; Steele PH; Kamilaris J; Burks AW
    J Allergy Clin Immunol; 2009 Aug; 124(2):286-91, 291.e1-6. PubMed ID: 19477496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.